Claire Gaveriaux-Ruff

Claire Gaveriaux-Ruff

Auto-generated profile, based on publicly available information

Claire Gaveriaux-Ruff

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Translational Medicine and Neurogenetics, Illkirch, France

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BKB L Kieffer
B L Kieffer
KBK Befort
K Befort
CGC Gaveriaux-Ruff
C Gaveriaux-Ruff
CHC G Hirth
C G Hirth
A random primed expression cDNA library was constructed from the RNA of NG 108-15 cells. Pools of plasmid DNA were transfected into COS cells, which were screened for their ability to bind 3H-labeled Tyr-D-Thr-Gly-Phe-Leu-Thr, a tritiated agonist for the delta-opioid receptor. A cDNA was isolated that encodes a 371-amino acid-residue protein presenting all the structural characteristics of receptors that interact with guanine nucleotide-binding proteins. Noticeable features are (i) the high hydrophobicity of the encoded protein, (ii) its low sequence similarity to both catecholamine receptors and peptide-binding receptors, although it presents the typical aspartate residue involved in catecholamine binding of the first group and the characteristic short third cytoplasmic loop of the second group. When expressed in COS cells, the receptor exhibits pharmacological properties similar to those of the native receptor: high-affinity binding sites for 3H-labeled Tyr-D-Thr-Gly-Phe-Leu-Thr (Kd = 1.4 nM), stereospecific binding sites for the - enantiomers of levorphanol and naloxone, and the selectivity profile of a delta receptor, as determined by competition experiments with a set of mu-, delta-, and kappa-opioid ligands.

1 April 2002 in Progress in Neurobiology
Verified
Journal Article
Closed access
BKBrigitte L Kieffer
Brigitte L Kieffer
CGClaire Gavériaux-Ruff
Claire Gavériaux-Ruff

1 December 2016 in Neuroscience
Verified
Journal Article
Closed access
LRLaurie-Anne Roeckel
Laurie-Anne Roeckel
GCGlenn-Marie Le Coz
Glenn-Marie Le Coz
CGClaire Gavériaux-Ruff
Claire Gavériaux-Ruff
FSFrédéric Simonin
Frédéric Simonin

1 October 2011 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
APAmynah A. Pradhan
Amynah A. Pradhan
KBKatia Befort
Katia Befort
CNChihiro Nozaki
Chihiro Nozaki
CGClaire Gavériaux-Ruff
Claire Gavériaux-Ruff
BKBrigitte L. Kieffer
Brigitte L. Kieffer

1 November 1993 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
NDN Dascal
N Dascal
WSW Schreibmayer
W Schreibmayer
NLN F Lim
N F Lim
WWW Wang
W Wang
CCC Chavkin
C Chavkin
DTD Trollinger
D Trollinger
Activity of several ion channels is controlled by heterotrimeric GTP-binding proteins (G proteins) via a membrane-delimited pathway that does not involve cytoplasmic intermediates. The best studied example is the K+ channel activated by muscarinic agonists in the atrium, which plays a crucial role in regulating the heartbeat. To enable studies of the molecular mechanisms of activation, this channel, denoted KGA, was cloned from a rat atrium cDNA library by functional coupling to coexpressed serotonin type 1A receptors in Xenopus oocytes. KGA displays regions of sequence homology to other inwardly rectifying channels as well as unique regions that may govern G-protein interaction. The expressed KGA channel is activated by serotonin 1A, muscarinic m2, and delta-opioid receptors via G proteins. KGA is activated by guanosine 5'-[gamma-thio]triphosphate in excised patches, confirming activation by a membrane-delimited pathway, and displays a conductance equal to that of the endogenous channel in atrial cells. The hypothesis that similar channels play a role in neuronal inhibition is supported by the cloning of a nearly identical channel (KGB1) from a rat brain cDNA library.

20 June 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GSGrégory Scherrer
Grégory Scherrer
PTPetra Tryoen-Tóth
Petra Tryoen-Tóth
DFDominique Filliol
Dominique Filliol
AMAudrey Matifas
Audrey Matifas
DLDelphine Laustriat
Delphine Laustriat
BKBrigitte L. Kieffer
Brigitte L. Kieffer
The combination of fluorescent genetically encoded proteins with mouse engineering provides a fascinating means to study dynamic biological processes in mammals. At present, green fluorescent protein (GFP) mice were mainly developed to study gene expression patterns or cell morphology and migration. Here we used enhanced GFP (EGFP) to achieve functional imaging of a G protein-coupled receptor (GPCR)in vivo. We created mice where the δ-opioid receptor (DOR) is replaced by an active DOR-EGFP fusion. Confocal imaging revealed detailed receptor neuroanatomy throughout the nervous system of knockin mice. Real-time imaging in primary neurons allowed dynamic visualization of drug-induced receptor trafficking. In DOR-EGFP animals, drug treatment triggered receptor endocytosis that correlated with the behavioral response. Mice with internalized receptors were insensitive to subsequent agonist administration, providing evidence that receptor sequestration limits drug efficacyin vivo. Direct receptor visualization in mice is a unique approach to receptor biology and drug design.